エピソード

  • Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer

    Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer
    2025/08/26

    Can you give patients one ADC after another? A renowned panel of experts interrogate this question and many more in this thought-provoking program.

    Credit available for this activity expires: 8/25/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002851?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    28 分
  • JC Virus Testing 101: What You Need to Know About JC Virus Testing in Multiple Sclerosis Care

    JC Virus Testing 101: What You Need to Know About JC Virus Testing in Multiple Sclerosis Care
    2025/08/25

    Do you know how John Cunningham (JC) virus assays work?

    Credit available for this activity expires: 8/22/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002825?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    20 分
  • The Basis of Success: Recognizing IgAN and Promoting Earlier Diagnosis to Facilitate Treatment Initiation

    The Basis of Success: Recognizing IgAN and Promoting Earlier Diagnosis to Facilitate Treatment Initiation
    2025/08/22

    IgA nephropathy is often diagnosed late. Recognizing and referring patients timely improves management and outcomes.

    Credit available for this activity expires: 8/19/2026

    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002763?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    31 分
  • Hormone Receptor-Positive Metastatic Breast Cancer: Novel Endocrine-Based Strategies and Options After Progression

    Hormone Receptor-Positive Metastatic Breast Cancer: Novel Endocrine-Based Strategies and Options After Progression
    2025/08/22

    Join here for expert analysis of the latest clinical trial data in HR-positive MBC and discussion of the clinical implications of these study results.

    Credit available for this activity expires: 8/18/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002835?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    19 分
  • Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer

    Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
    2025/08/20

    How confident are you navigating biomarker conversations with your gastric cancer patients?


    Credit available for this activity expires: 8/19/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002840?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    18 分
  • Long COVID in Context: A Closer Look at Post-Viral Syndrome and Management Approaches

    Long COVID in Context: A Closer Look at Post-Viral Syndrome and Management Approaches
    2025/08/19

    Are you up to date on long COVID’s impact, prevention, and management? Explore the latest evidence and expert perspectives here.

    Credit available for this activity expires: 8/19/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002795?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    35 分
  • Tumor-Like Masses, Abdominal Swelling, Pancreatic Involvement: Making Sense of IgG4-Related Disease, a Multiorgan Fibroinflammatory Condition

    Tumor-Like Masses, Abdominal Swelling, Pancreatic Involvement: Making Sense of IgG4-Related Disease, a Multiorgan Fibroinflammatory Condition
    2025/08/13

    Immunoglobulin G4-related disease (IgG4-RD) isn't always obvious; join our expert roundtable to learn when to suspect it and how to detect flares.

    Credit available for this activity expires: 8/12/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002730?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    28 分
  • Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach

    Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach
    2025/08/08

    When do you first test for ESR1 mutation in hormone receptor (HR)-positive advanced breast cancer (ABC)?

    Credit available for this activity expires: 8/7/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002782?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    37 分